ConductScience.org, home

Paper36985237

Pseudomonas aeruginosa and the Complement System: A Review of the Evasion Strategies.

González-Alsina A and 3 others. Microorganisms, 2023. Cited by 18 papers, by iCite.

Cite this record

ConductScience Library. Pseudomonas aeruginosa and the Complement System: A Review of the Evasion Strategies. Papers, record 36985237. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/36985237

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Pseudomonas aeruginosa and the Complement System: A Review of the Evasion Strategies.
PubMed
Journal
Microorganisms
PubMed
Year
2023
PubMed
Publication types
Journal Article, Review
PubMed
Citations, by iCite
18
iCite
Relative citation ratio, by iCite
2.4
iCite
Revised in PubMed
2023-03-31
PubMed

Authors4

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1González-Alsina AAlex
2Mateu-Borrás MMargalida
3Doménech-Sánchez AAntoniohttps://orcid.org/0000-0002-7892-8349
4Albertí SSebastián

Source PubMed

Download CSV of authors

Topics0

NLM's MeSH indexing of the paper, its major topics first.

None in this release.

Grants1

Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.

Grant, as the record writes itAgencyCountryNIH projectStated by
PID2021-127281OB-I00Ministerio de Ciencia e Innovación/ Agencia Estatal de InvestigaciónPubMed

Source PubMed

Download CSV of grants

References97

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
122226846Structure and function of OprD protein in Pseudomonas aeruginosa: from antibiotic resistance to novel therapies.Int J Med Microbiol2012https://conductscience.org/library/papers/22226846PubMed
221747788Pseudomonas aeruginosa: resistance to the max.Front Microbiol2011https://conductscience.org/library/papers/21747788PubMed
328373189Results from a 13-Year Prospective Cohort Study Show Increased Mortality Associated with Bloodstream Infections Caused by Pseudomonas aeruginosa Compared to Other Bacteria.Antimicrob Agents Chemother2017https://conductscience.org/library/papers/28373189PubMed
49284161Mucoid Pseudomonas aeruginosa in cystic fibrosis: characterization of muc mutations in clinical isolates and analysis of clearance in a mouse model of respiratory infection.Infect Immun1997https://conductscience.org/library/papers/9284161PubMed
511179370Role of alginate O acetylation in resistance of mucoid Pseudomonas aeruginosa to opsonic phagocytosis.Infect Immun2001https://conductscience.org/library/papers/11179370PubMed
623408095Recognition of lipid A variants by the TLR4-MD-2 receptor complex.Front Cell Infect Microbiol2013https://conductscience.org/library/papers/23408095PubMed
78561477Microbial biofilms.Annu Rev Microbiol1995https://conductscience.org/library/papers/8561477PubMed
87895224Preliminary communication 7-O-carbamoyl-L-glycero-D-manno-heptose: a new core constituent in the lipopolysaccharide of Pseudomonas aeruginosa.Carbohydr Res1995https://conductscience.org/library/papers/7895224PubMed
99642237Protease IV, a unique extracellular protease and virulence factor from Pseudomonas aeruginosa.J Biol Chem1998https://conductscience.org/library/papers/9642237PubMed
1019892865Role of neutrophils, MyD88-mediated neutrophil recruitment, and complement in antibody-mediated defense against Pseudomonas aeruginosa keratitis.Invest Ophthalmol Vis Sci2010https://conductscience.org/library/papers/19892865PubMed
1128634241Psl Produced by Mucoid Pseudomonas aeruginosa Contributes to the Establishment of Biofilms and Immune Evasion.mBio2017https://conductscience.org/library/papers/28634241PubMed
1211912497Human Toll-like receptor 4 recognizes host-specific LPS modifications.Nat Immunol2002https://conductscience.org/library/papers/11912497PubMed
1326074922Complement System Part II: Role in Immunity.Front Immunol2015https://conductscience.org/library/papers/26074922PubMed
148253063Three-dimensional structure of the alkaline protease of Pseudomonas aeruginosa: a two-domain protein with a calcium binding parallel beta roll motif.EMBO J1993https://conductscience.org/library/papers/8253063PubMed
159790526Lipid A acylation and bacterial resistance against vertebrate antimicrobial peptides.Cell1998https://conductscience.org/library/papers/9790526PubMed
1621951860Pseudomonas aeruginosa Psl polysaccharide reduces neutrophil phagocytosis and the oxidative response by limiting complement-mediated opsonization.Cell Microbiol2012https://conductscience.org/library/papers/21951860PubMed
1725964476Identification of OprF as a complement component C3 binding acceptor molecule on the surface of Pseudomonas aeruginosa.Infect Immun2015https://conductscience.org/library/papers/25964476PubMed
1812724392Proteome analysis of extracellular proteins regulated by the las and rhl quorum sensing systems in Pseudomonas aeruginosa PAO1.Microbiology (Reading)2003https://conductscience.org/library/papers/12724392PubMed
1928278205Complement effectors, C5a and C3a, in cystic fibrosis lung fluid correlate with disease severity.PLoS One2017https://conductscience.org/library/papers/28278205PubMed
2015819873Clinical features and outcome of patients with community-acquired Pseudomonas aeruginosa bacteraemia.Clin Microbiol Infect2005https://conductscience.org/library/papers/15819873PubMed

See all 97 referencesDownload CSV of references

Cited by16

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 18 citations.

PMIDTitleJournalYearIn PapersSource
42954674Bacterial toxin activation and deployment: Context-dependent links to host immune remodeling.Virulence2026https://conductscience.org/library/papers/42954674PubMed
42696382Convergent evolution of immune evasion in ESKAPE pathogens: A cross-pathogen architecture of conserved host-defense checkpoints.Eur J Microbiol Immunol (Bp)2026https://conductscience.org/library/papers/42696382PubMed
42294690Calcium regulation of Pseudomonas aeruginosa metabolism.Appl Environ Microbiol2026https://conductscience.org/library/papers/42294690PubMed
41924425Immune evasion of multidrug-resistant bacteria: insights from lung innate immune cells and targeted therapies.Front Cell Infect Microbiol2026https://conductscience.org/library/papers/41924425PubMed
41901545Molecular Mechanisms Underlying the Pathogenicity of Pseudomonas aeruginosa.Medicina (Kaunas)2026https://conductscience.org/library/papers/41901545PubMed
41871098Transthyretin is a novel innate immune effector against Gram negative bacteria.PLoS Pathog2026https://conductscience.org/library/papers/41871098PubMed
40821801Fc-modification of anti-PcrV gene-encoded antibodies modulates complement-mediated killing of Pseudomonas aeruginosa.Front Immunol2025https://conductscience.org/library/papers/40821801PubMed
40761286A comprehensive review of the pathogenic mechanisms of Pseudomonas aeruginosa: synergistic effects of virulence factors, quorum sensing, and biofilm formation.Front Microbiol2025https://conductscience.org/library/papers/40761286PubMed
40376408The brightness of lectins conjugated to quantum dots.Biophys Rev2025https://conductscience.org/library/papers/40376408PubMed
39670709Novel broadly reactive monoclonal antibody protects against Pseudomonas aeruginosa infection.Infect Immun2025https://conductscience.org/library/papers/39670709PubMed
38903499The potential of bacterial anti-phagocytic proteins in suppressing the clearance of extracellular vesicles mediated by host phagocytosis.Front Immunol2024https://conductscience.org/library/papers/38903499PubMed
38734892Determinants of bacterial survival and proliferation in blood.FEMS Microbiol Rev2024https://conductscience.org/library/papers/38734892PubMed
38510967Factor H-related protein 1 promotes complement-mediated opsonization of Pseudomonas aeruginosa.Front Cell Infect Microbiol2024https://conductscience.org/library/papers/38510967PubMed
38235716Antibody-Mediated Serum Resistance Protects Pseudomonas aeruginosa During Bloodstream Infections.J Infect Dis2024https://conductscience.org/library/papers/38235716PubMed
37508322Screening for Antimicrobial Resistance and Genes of Exotoxins in Pseudomonas aeruginosa Isolates from Infected Dogs and Cats in Poland.Antibiotics (Basel)2023https://conductscience.org/library/papers/37508322PubMed
37388786Anti-bacterial mechanism of baicalin-tobramycin combination on carbapenem-resistant Pseudomonas aeruginosa.World J Clin Cases2023https://conductscience.org/library/papers/37388786PubMed

Download CSV of cited by

Genes3

The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.

GeneNCBI Gene IDLinked byIn GenesSource
ALG879053PubTator's text mininghttps://conductscience.org/library/genes/79053NCBI Gene
OPRD14985PubTator's text mininghttps://conductscience.org/library/genes/4985NCBI Gene
RAPH165059PubTator's text mininghttps://conductscience.org/library/genes/65059NCBI Gene

Download CSV of genes

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Trials
  • Comments and corrections
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/36985237

GET https://conductscience.org/api/papers/v1/36985237/references?page=2